Cancer is a leading cause of death worldwide, and current treatments are often ineffective or have serious side effects. Researchers are constantly looking for new and innovative ways to treat cancer, and one promising new approach is wireless electrical–molecular quantum signalling (WEMQS).
We have recently published the world's first quantum therapeutic article in the prestigious journal Nature Nanotechnology. The article describes a new technique called wireless electrical–molecular quantum signalling (WEMQS) that can be used to kill cancer cells in a targeted and non-invasive manner.
WEMQS works by attaching tiny nanoelectrodes to the surface of cancer cells. When an electrical signal is applied to the nanoelectrodes, it creates an electric field that interacts with the molecules on the cell surface. This interaction can trigger a variety of cellular responses, including apoptosis (programmed cell death).
In our study, we showed that WEMQS could be used to trigger apoptosis in glioma cells, a type of aggressive brain cancer. We also showed that WEMQS was more effective at killing cancer cells than traditional chemotherapy drugs.
WEMQS is still in the early stages of development, but it has the potential to be a revolutionary new approach to cancer treatment. It is a non-invasive technique that can be used to target cancer cells specifically, without harming healthy cells. Additionally, WEMQS can be used to deliver drugs to cancer cells in a targeted manner.
We are excited about the potential of WEMQS to improve the lives of cancer patients. We are currently working to develop new ways to deliver nanoelectrodes to cancer cells and to improve the precision with which we can control the electric field generated by the nanoelectrodes. We believe that WEMQS has the potential to be a major breakthrough in cancer treatment.
Citation:
Jain, A., Gosling, J., Liu, S., Wang, H., Stone, E. M., Chakraborty, S., Jayaraman, P.-S., Smith, S., Amabilino, D. B., Fromhold, M., Long, Y.-T., Pérez-García, L., Turyanska, L., Rahman, R., & Rawson, F. J. (2023). Wireless electrical–molecular quantum signalling for cancer cell apoptosis. Nature Nanotechnology, 18(9), 1-10.
Link to the article:
Background
WEMQS is a technique that uses electrical signals to control molecular processes in cells. This can be done by attaching tiny nanoelectrodes to the surface of cells. When an electrical signal is applied to the nanoelectrodes, it creates an electric field that can interact with the molecules on the cell surface. This interaction can trigger a variety of cellular responses, including apoptosis (programmed cell death).
WEMQS has been shown to be effective in killing cancer cells in a variety of laboratory studies. In one study, researchers used WEMQS to trigger apoptosis in glioma cells, a type of aggressive brain cancer. The researchers found that WEMQS was more effective at killing cancer cells than traditional chemotherapy drugs.
WEMQS is still in the early stages of development, but it has the potential to be a revolutionary new approach to cancer treatment. It is a non-invasive technique that can be used to target cancer cells specifically, without harming healthy cells. Additionally, WEMQS can be used to deliver drugs to cancer cells in a targeted manner.
Advantages of WEMQS over traditional cancer treatments
WEMQS has a number of advantages over traditional cancer treatments, such as chemotherapy and radiation therapy. First, WEMQS is non-invasive. This means that it does not require any surgery or other invasive procedures. Second, WEMQS is highly targeted. It can be used to kill cancer cells specifically, without harming healthy cells. This is in contrast to chemotherapy and radiation therapy, which can damage both healthy and cancerous cells. Third, WEMQS can be used to deliver drugs to cancer cells in a targeted manner. This can help to reduce the side effects of chemotherapy drugs.
Challenges and future directions
One of the main challenges facing WEMQS is developing safe and effective ways to deliver nanoelectrodes to cancer cells. Researchers are currently working on developing new methods for delivering nanoelectrodes, such as using nanoparticles or viruses.
Another challenge is developing ways to control the electric field generated by the nanoelectrodes with high precision. This is important for ensuring that the electric field is strong enough to trigger apoptosis in cancer cells, but not so strong that it damages healthy cells.
Despite these challenges, WEMQS is a promising new approach to cancer treatment with the potential to revolutionize the way we treat cancer. Researchers are working actively to address the challenges facing WEMQS, and it is likely that we will see WEMQS used in clinical trials in the near future.
Comments